Leidos Awarded Organ Procurement and Transplantation Network Operations Contract
Leidos (NYSE:LDOS) has secured a contract to modernize the Organ Procurement and Transplant Network (OPTN). The $235 million contract, awarded by the U.S. Department of Health and Human Services, includes a one-year base period with four one-year options. The project aims to improve the system that delivers organ transplant information to patients, donors, and healthcare providers.
As part of this multiple-award contract, Leidos will compete with other vendors to modernize key aspects of the organ transplant system, focusing on enhancing transparency, performance, governance, and efficiency. The initiative will benefit over 100,000 people on the national organ transplant waitlist and represents the most significant OPTN reforms in nearly 40 years.
Leidos (NYSE:LDOS) ha ottenuto un contratto per modernizzare la Rete di Procurement e Trapianto di Organi (OPTN). Il contratto del valore di 235 milioni di dollari, assegnato dal Dipartimento della Salute e dei Servizi Umani degli Stati Uniti, prevede un periodo base di un anno con quattro opzioni annuali. L'obiettivo del progetto è migliorare il sistema che fornisce informazioni sui trapianti di organi a pazienti, donatori e operatori sanitari.
Come parte di questo contratto a più assegnatari, Leidos competitorà con altri fornitori per modernizzare aspetti chiave del sistema di trapianto di organi, concentrandosi sul miglioramento della trasparenza, delle prestazioni, della governance e dell'efficienza. L'iniziativa avrà un impatto su oltre 100.000 persone nella lista d'attesa nazionale per i trapianti di organi e rappresenta le riforme più significative dell'OPTN negli ultimi 40 anni.
Leidos (NYSE:LDOS) ha conseguido un contrato para modernizar la Red de Adquisición y Trasplante de Órganos (OPTN). El contrato de 235 millones de dólares, otorgado por el Departamento de Salud y Servicios Humanos de EE. UU., incluye un período base de un año con cuatro opciones anuales. El proyecto tiene como objetivo mejorar el sistema que proporciona información sobre trasplantes de órganos a pacientes, donantes y proveedores de atención médica.
Como parte de este contrato de múltiples adjudicaciones, Leidos competirá con otros proveedores para modernizar aspectos clave del sistema de trasplante de órganos, enfocándose en mejorar la transparencia, el rendimiento, la gobernanza y la eficiencia. La iniciativa beneficiará a más de 100,000 personas en la lista de espera nacional para trasplantes de órganos y representa las reformas más significativas del OPTN en casi 40 años.
Leidos (NYSE:LDOS)가 장기 장착 정보 네트워크(OPTN)를 현대화하기 위한 계약을 체결했습니다. 미국 보건복지부가 수여한 2억 3천 5백만 달러 규모의 계약은 1년의 기본 기간과 4개의 1년 옵션을 포함합니다. 이 프로젝트는 환자, 기증자 및 의료 제공자에게 장기 이식 정보를 제공하는 시스템을 개선하는 것을 목표로 합니다.
이 다수 수여 계약의 일환으로, Leidos는 장기 이식 시스템의 주요 측면을 현대화하기 위해 다른 공급업체와 경쟁하며, 투명성, 성능, 거버넌스 및 효율성을 향상시키는 데 중점을 둡니다. 이 이니셔티브는 국가 장기 이식 대기 명단의 10만명 이상에게 혜택을 줄 것이며, 거의 40년 만에 가장 중요한 OPTN 개혁을 나타냅니다.
Leidos (NYSE:LDOS) a obtenu un contrat pour moderniser le Réseau d'Obtention et de Transplantation d'Organes (OPTN). Le contrat d'un montant de 235 millions de dollars, attribué par le Département de la Santé et des Services sociaux des États-Unis, comprend une période de base d'un an avec quatre options d'un an. Le projet vise à améliorer le système qui fournit des informations sur les transplantations d'organes aux patients, aux donneurs et aux professionnels de la santé.
Dans le cadre de ce contrat à multiples attributaires, Leidos devra rivaliser avec d'autres fournisseurs pour moderniser les aspects clés du système de transplantation d'organes, en se concentrant sur l'amélioration de la transparence, des performances, de la gouvernance et de l'efficacité. L'initiative bénéficiera à plus de 100 000 personnes figurant sur la liste d'attente nationale pour les transplantations d'organes et représente les réformes les plus significatives de l'OPTN depuis près de 40 ans.
Leidos (NYSE:LDOS) hat einen Vertrag zur Modernisierung des Organbeschaffungs- und Transplantationsnetzwerks (OPTN) gesichert. Der mit 235 Millionen Dollar dotierte Vertrag, der vom US-Gesundheitsministerium verliehen wurde, umfasst eine einjährige Grundlaufzeit mit vier einjährigen Optionen. Ziel des Projekts ist es, das System zu verbessern, das Informationen über Organtransplantationen an Patienten, Spender und Gesundheitsdienstleister übermittelt.
Im Rahmen dieses Vertrages mit mehreren Vergaben wird Leidos mit anderen Anbietern um die Modernisierung wesentlicher Aspekte des Organtransplantationssystems konkurrieren, wobei der Schwerpunkt auf der Verbesserung von Transparenz, Leistung, Governance und Effizienz liegt. Die Initiative wird über 100.000 Menschen auf der nationalen Warteliste für Organtransplantationen zugutekommen und stellt die bedeutendsten Reformen des OPTN seit fast 40 Jahren dar.
- Secured new contract worth $235 million
- Multiple-year potential through four one-year options
- Opportunity to compete for additional tasks within the contract scope
- Large addressable market of over 100,000 patients
- Contract requires competing with other vendors for tasks
- Base period to one year
Insights
This
The OPTN modernization project aligns with federal healthcare IT modernization trends and positions Leidos well for future health technology contracts. With over 100,000 patients on organ waitlists, successful execution could strengthen Leidos' reputation in critical healthcare systems. The company's experience with large-scale health records systems provides competitive advantages in task order competitions.
RESTON, VA / ACCESSWIRE / November 8, 2024 / Leidos
Leidos (NYSE:LDOS) announced a new contract to modernize the Organ Procurement and Transplant Network (OPTN), a critical system that delivers vital organ transplant information to patients, donors, and healthcare providers. The contract was awarded by the U.S. Department of Health and Human Services through its Health Resources and Services Administration (HRSA). This multiple-award, indefinite delivery/indefinite quantity contract has a total potential value of
"Every 10 minutes, someone is added to the transplant waiting list," said Liz Porter, Leidos Health & Civil Sector president. "Patients, donors, families, and physicians depend on timely and accurate data from the OPTN to facilitate life-saving transplants. By providing improved access to information and deploying modernized tools, we are dedicated to equipping all involved with the resources they need to make critical decisions."
Under the contract, Leidos will have the opportunity to compete with other vendors to win tasks to modernize key pieces of the organ transplant system to improve transparency, performance, governance, and efficiency across the donation and transplantation process. This effort will benefit more than 100,000 people on the national organ transplant waitlist.
With its deep expertise in technology, health systems, and large-scale electronic health record implementations, Leidos is uniquely positioned to collaborate with HRSA on planning and delivering the OPTN modernization.
This initiative, representing the most significant reforms of the OPTN in nearly four decades, is aimed at improving health outcomes and better serving patients and families.
About Leidos
Leidos is a Fortune 500® innovation company rapidly addressing the world's most vexing challenges in national security and health. The company's global workforce of 48,000 collaborates to create smarter technology solutions for customers in heavily regulated industries. Headquartered in Reston, Virginia, Leidos reported annual revenues of approximately
View additional multimedia and more ESG storytelling from Leidos on 3blmedia.com.
Contact Info:
Spokesperson: Leidos
Website: https://www.3blmedia.com/profiles/leidos
Email: info@3blmedia.com
SOURCE: Leidos
View the original press release on accesswire.com
FAQ
What is the value of Leidos (LDOS) OPTN modernization contract?
How many people will benefit from Leidos (LDOS) OPTN modernization project?
What is the duration of Leidos (LDOS) OPTN contract?
What will Leidos (LDOS) do under the OPTN contract?
